Takuya Miyazaki

2.7k total citations
127 papers, 1.7k citations indexed

About

Takuya Miyazaki is a scholar working on Molecular Biology, Hematology and Surgery. According to data from OpenAlex, Takuya Miyazaki has authored 127 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 28 papers in Hematology and 23 papers in Surgery. Recurrent topics in Takuya Miyazaki's work include Acute Myeloid Leukemia Research (12 papers), RNA Interference and Gene Delivery (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Takuya Miyazaki is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), RNA Interference and Gene Delivery (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Takuya Miyazaki collaborates with scholars based in Japan, United States and China. Takuya Miyazaki's co-authors include Horacio Cabral, S Kohno, N Ishikawa, Kotaro Mitsutake, Kenichi Tanaka, Shigefumi Maesaki, Kenji Hara, Kazunori Kataoka, Taehun Hong and Yoshiaki Ishigatsubo and has published in prestigious journals such as Cell, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Takuya Miyazaki

110 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takuya Miyazaki Japan 24 681 268 265 183 183 127 1.7k
Jiayin Shen China 21 725 1.1× 317 1.2× 503 1.9× 186 1.0× 169 0.9× 53 1.8k
Eric L. Kaijzel Netherlands 31 711 1.0× 534 2.0× 279 1.1× 187 1.0× 67 0.4× 69 2.5k
Yan Fang China 22 824 1.2× 143 0.5× 344 1.3× 183 1.0× 241 1.3× 72 1.9k
Liubing Li China 18 309 0.5× 184 0.7× 89 0.3× 280 1.5× 307 1.7× 87 1.6k
Anastasia Malek Russia 28 1.6k 2.4× 291 1.1× 188 0.7× 103 0.6× 103 0.6× 108 2.6k
François Plénat France 27 665 1.0× 283 1.1× 347 1.3× 203 1.1× 64 0.3× 95 2.0k
Junming Li China 31 1.1k 1.6× 643 2.4× 255 1.0× 266 1.5× 435 2.4× 115 2.5k
Joo Seop Chung South Korea 23 296 0.4× 394 1.5× 515 1.9× 116 0.6× 116 0.6× 101 1.8k
Hee‐Seung Bom South Korea 25 526 0.8× 145 0.5× 408 1.5× 151 0.8× 51 0.3× 126 2.6k

Countries citing papers authored by Takuya Miyazaki

Since Specialization
Citations

This map shows the geographic impact of Takuya Miyazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Miyazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Miyazaki more than expected).

Fields of papers citing papers by Takuya Miyazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Miyazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Miyazaki. The network helps show where Takuya Miyazaki may publish in the future.

Co-authorship network of co-authors of Takuya Miyazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Miyazaki. A scholar is included among the top collaborators of Takuya Miyazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Miyazaki. Takuya Miyazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Miyazaki, Takuya, Hiroyuki Takahashi, Takaaki Takeda, et al.. (2025). Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell Lymphoma. Internal Medicine. 64(18). 2716–2722. 2 indexed citations
4.
Chen, Pengwen, Wenqian Yang, Koji Nagaoka, et al.. (2023). An IL‐12‐Based Nanocytokine Safely Potentiates Anticancer Immunity through Spatiotemporal Control of Inflammation to Eradicate Advanced Cold Tumors. Advanced Science. 10(10). e2205139–e2205139. 27 indexed citations
5.
Fujisawa, Shin, Masatsugu Tanaka, Maki Hagihara, et al.. (2023). Prognostic significance of the CFA ratio for newly diagnosed acute myeloid leukemia: A multicenter retrospective study. Hematological Oncology. 42(1). e3228–e3228. 2 indexed citations
6.
Najima, Yuho, Takayoshi Tachibana, Kaito Harada, et al.. (2023). A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation. Blood. 142(Supplement 1). 3606–3606. 1 indexed citations
7.
Chen, Pengwen, Wenqian Yang, Taehun Hong, et al.. (2022). Nanocarriers escaping from hyperacidified endo/lysosomes in cancer cells allow tumor-targeted intracellular delivery of antibodies to therapeutically inhibit c-MYC. Biomaterials. 288. 121748–121748. 34 indexed citations
8.
Miyazaki, Takuya, Shaoyi Chen, Kazunori Igarashi, et al.. (2022). A Hoechst Reporter Enables Visualization of Drug Engagement In Vitro and In Vivo: Toward Safe and Effective Nanodrug Delivery. ACS Nano. 16(8). 12290–12304. 11 indexed citations
9.
Yang, Wenqian, Takuya Miyazaki, Pengwen Chen, et al.. (2021). Block catiomer with flexible cationic segment enhances complexation with siRNA and the delivery performance in vitro. Science and Technology of Advanced Materials. 22(1). 850–863. 7 indexed citations
10.
Nagamatsu, Takeshi, Horacio Cabral, Takuya Miyazaki, et al.. (2021). Thrombomodulin promotes placental function by up-regulating placental growth factor via inhibition of high-mobility-group box 1 and hypoxia-inducible factor 1α. Placenta. 111. 1–9. 8 indexed citations
11.
Miyazaki, Takuya, Yoshiaki Shoji, Shintaro Fujii, & Takanori Fukushima. (2021). A single-molecule conductance study on the rotational isomers of a hexaarylbenzene derivative carrying dipolar rotating units. Japanese Journal of Applied Physics. 60(10). 108002–108002. 3 indexed citations
12.
Suzuki, Kazumi, Yutaka Miura, Yuki Mochida, et al.. (2019). Glucose transporter 1-mediated vascular translocation of nanomedicines enhances accumulation and efficacy in solid tumors. Journal of Controlled Release. 301. 28–41. 70 indexed citations
13.
Fujisawa, Shin, Taisei Suzuki, Jun Aoki, et al.. (2017). Clinical Impact of Sarcopenia and Skeletal Muscle Mass Change during Chemotherapy on Outcomes of Diffuse Large B-Cell Lymphoma. Blood. 130. 5221–5221. 1 indexed citations
15.
Sakai, Tomomi, Takuya Miyazaki, Dong-Mi Shin, et al.. (2017). DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice. Journal of Autoimmunity. 81. 13–23. 30 indexed citations
16.
Miyazaki, Takuya, et al.. (2014). Topical morphine gel for pain management in head and neck cancer patients. Auris Nasus Larynx. 41(5). 496–498. 10 indexed citations
17.
Miyazaki, Takuya, et al.. (2012). Mohs'chemosurgery in palliative care. JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY. 22(2). 247–253. 5 indexed citations
18.
Krilov, Lada, et al.. (2011). Dual mode of glucagon receptor internalization: role of PKCalpha, GRKs and beta-arrestins.. Experimental Cell Research. 317(20). 5 indexed citations
20.
Asaka, Masahiro, Masashi Kato, Yuichi Sato, & Takuya Miyazaki. (1992). [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].. PubMed. 50(1). 104–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026